Intravenous alteplase versus rescue endovascular procedure in patients with proximal middle cerebral artery occlusion

International Journal of Stroke

Volumn 10, Issue 2, 2015, Pages 188-193

  Strbian, Daniel ^a   Mustanoja, Satu ^a   Pekkola, Johanna ^a   Putaala, Jukka ^a   Haapaniemi, Elena ^a   Paananen, Tapio ^a   Kaste, Markku ^a   Lappalainen, Kimmo ^a   Tatlisumak, Turgut ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Acute stroke therapy; Cerebral infarction; Endovascular; Ischaemic stroke; Thrombolysis

Indexed keywords

ALTEPLASE; GLUCOSE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AGE DISTRIBUTION; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONSCIOUS SEDATION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ENDOVASCULAR SURGERY; FEMALE; GENERAL ANESTHESIA; GLUCOSE BRAIN LEVEL; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; MEDICAL HISTORY; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPENSITY SCORE; RANKIN SCALE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TIME TO TREATMENT; BRAIN ANGIOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; FIBRINOLYTIC THERAPY; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRAVENOUS DRUG ADMINISTRATION; TIME; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; CEREBRAL ANGIOGRAPHY; ENDOVASCULAR PROCEDURES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; THROMBOLYTIC THERAPY; TIME FACTORS; TIME-TO-TREATMENT; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84921532285     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00918.x     Document Type: Article

References (27)

1. Lees KR, Bluhmki E, von Kummer R etal. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375:1695-1703.
2. Christou I, Alexandrov AV, Burgin WS etal. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 2000; 31:1812-1816.
3. Demchuk AM, Tanne D, Hill MD etal. Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology 2001; 57:474-480.
4. Saqqur M, Uchino K, Demchuk AM etal. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38:948-954.
5. del Zoppo GJ, Poeck K, Pessin MS etal. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32:78-86.
6. The Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40:2761-2768.
7. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke 2007; 38:2127-2135.
8. Furlan AJ, Higashida R, Wechsler L etal. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study-A randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282:2003-2011.
9. Smith WS, Sung G, Saver J etal. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008; 39:1205-1212.
10. Ellis JA, Youngerman BE, Higashida RT, Altschul D, Meyers PM. Endovascular treatment strategies for acute ischemic stroke. Int J Stroke 2011; 6:511-522.
11. Meretoja A, Putaala J, Tatlisumak T etal. Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke 2010; 41:1450-1458.
12. Mattle HP, Arnold M, Georgiadis D etal. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008; 39:379-383.
13. Bastianello S, Pierallini A, Colonnese C etal. Hyperdense middle cerebral artery CT sign. Comparison with angiography in the acute phase of ischemic supratentorial infarction. Neuroradiology 1991; 33:207-211.
14. Gacs G, Fox AJ, Barnett HJ, Vinuela F. CT visualization of intracranial arterial thromboembolism. Stroke 1983; 14:756-762.
15. Leys D, Pruvo JP, Godefroy O, Rondepierre P, Leclerc X. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke 1992; 23:317-324.
16. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985; 312:932-936.
17. Adams HP Jr, Bendixen BH, Kappelle LJ etal. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24:35-41.
18. Hacke W, Kaste M, Fieschi C etal. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998; 352:1245-1251.
19. Arnold M, Schroth G, Nedeltchev K etal. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002; 33:1828-1833.
20. Neumann-Haefelin T, du Mesnil de Rochemont R, Fiebach JB etal. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 2004; 35:109-114.
21. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1587.
22. Hacke W, Kaste M, Bluhmki E etal. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359:1317-1329.
23. Hacke W, Kaste M, Fieschi C etal. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274:1017-1025.
24. Mazighi M, Serfaty JM, Labreuche J etal. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009; 8:802-809.
25. Rubiera M, Ribo M, Pagola J etal. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study. Stroke 2011; 42:993-997.
26. Abou-Chebl A, Lin R, Hussain MS etal. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke 2010; 41:1175-1179.
27. Meyers PM, Schumacher HC, Higashida RT etal. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009; 119:2235-2249.